Stocks News

LAST PRICE
4.3700
TODAY'S CHANGE (%)
Trending Down-0.0600 (-1.3544%)

Bid / Lots
4.2600/ 3
Ask / Lots
4.4400/ 3
Open / Previous Close
4.4400 / 4.4300
Day Range
Low 4.3501
High 4.4400
52 Week Range
Low 2.1200
High 4.9500
Volume
26,869
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 10, 2024
- DJ Diamedica Therapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 7:14AM ET on Thursday Oct 10, 2024 by Dow Jones
  7:14AM ET on Thursday Oct 10, 2024 by Dow Jones
  Companies Mentioned: DMAC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/DMAC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 10, 2024 07:14 ET (11:14 GMT)
Oct 9, 2024
- DiaMedica Says It Receives South Africa Approval to Start Mid-Stage Trial for Preeclampsia Treatment, from 9:12AM ET on Wednesday Oct 09, 2024 by MT Newswires
  9:12AM ET on Wednesday Oct 09, 2024 by MT Newswires
  Companies Mentioned: DMAC
  09:12 AM EDT, 10/09/2024 (MT Newswires) -- DiaMedica Therapeutics (DMAC) said Wednesday that it has received regulatory approval from the South African Health Products Regulatory Authority to begin a mid-stage clinical trial with DM199 to treat pree...
- DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia, from 8:27AM ET on Wednesday Oct 09, 2024 by Dow Jones
  8:27AM ET on Wednesday Oct 09, 2024 by Dow Jones
  Companies Mentioned: DMAC
  
  (END) Dow Jones Newswires
  
  October 09, 2024 08:27 ET (12:27 GMT)
Oct 7, 2024
- --HC Wainwright Initiates DiaMedica Therapeutics at Buy With $7 Price Target, from 8:47AM ET on Monday Oct 07, 2024 by MT Newswires
  8:47AM ET on Monday Oct 07, 2024 by MT Newswires
  Companies Mentioned: DMAC
  08:47 AM EDT, 10/07/2024 (MT Newswires) -- ...
- DJ Diamedica Therapeutics Initiated at Buy by HC Wainwright & Co., from 7:01AM ET on Monday Oct 07, 2024 by Dow Jones
  7:01AM ET on Monday Oct 07, 2024 by Dow Jones
  Companies Mentioned: DMAC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/DMAC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 07, 2024 07:01 ET (11:01 GMT)

Yesterday
- --JMP Securities Initiates Instil Bio at Market Perform, from 8:23AM ET on Monday Nov 04, 2024 by MT Newswires
  8:23AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: TIL
- DJ Instil Bio Initiated at Market Perform by JMP Securities, from 5:14AM ET on Monday Nov 04, 2024 by Dow Jones
  5:14AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: TIL
Oct 18, 2024
- DJ Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity, from 10:45AM ET on Friday Oct 18, 2024 by Dow Jones
  10:45AM ET on Friday Oct 18, 2024 by Dow Jones
  Companies Mentioned: TNYA
- DJ Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 7:00AM ET on Friday Oct 18, 2024 by Dow Jones
  7:00AM ET on Friday Oct 18, 2024 by Dow Jones
  Companies Mentioned: TNYA
Oct 17, 2024
- Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM, from 4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
  4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
  Companies Mentioned: TNYA
Oct 15, 2024
- atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit, from 8:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
  8:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
  Companies Mentioned: ATAI
Oct 10, 2024
- DJ Cabaletta Bio Initiated at Buy by UBS, from 9:39AM ET on Thursday Oct 10, 2024 by Dow Jones
  9:39AM ET on Thursday Oct 10, 2024 by Dow Jones
  Companies Mentioned: CABA
- UBS Initiates Cabaletta Bio at Buy With $10 Price Target, from 8:53AM ET on Thursday Oct 10, 2024 by MT Newswires
  8:53AM ET on Thursday Oct 10, 2024 by MT Newswires
  Companies Mentioned: CABA

DiaMedica Therapeutics Inc
NASDAQ:DMACUnited States

Search Criteria

Oct 10, 2024

DJ Diamedica Therapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 7:14AM ET on Thursday Oct 10, 2024 by Dow Jones

Oct 9, 2024

DiaMedica Says It Receives South Africa Approval to Start Mid-Stage Trial for Preeclampsia Treatment, from 9:12AM ET on Wednesday Oct 09, 2024 by MT Newswires

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia, from 8:27AM ET on Wednesday Oct 09, 2024 by Dow Jones

Oct 7, 2024

--HC Wainwright Initiates DiaMedica Therapeutics at Buy With $7 Price Target, from 8:47AM ET on Monday Oct 07, 2024 by MT Newswires

DJ Diamedica Therapeutics Initiated at Buy by HC Wainwright & Co., from 7:01AM ET on Monday Oct 07, 2024 by Dow Jones

Peers Headlines

Yesterday

--JMP Securities Initiates Instil Bio at Market Perform, from 8:23AM ET on Monday Nov 04, 2024 by MT Newswires

DJ Instil Bio Initiated at Market Perform by JMP Securities, from 5:14AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 18, 2024

DJ Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity, from 10:45AM ET on Friday Oct 18, 2024 by Dow Jones

DJ Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 7:00AM ET on Friday Oct 18, 2024 by Dow Jones

Oct 17, 2024

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM, from 4:30PM ET on Thursday Oct 17, 2024 by Dow Jones

Oct 15, 2024

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit, from 8:00AM ET on Tuesday Oct 15, 2024 by Dow Jones

Oct 10, 2024

DJ Cabaletta Bio Initiated at Buy by UBS, from 9:39AM ET on Thursday Oct 10, 2024 by Dow Jones

UBS Initiates Cabaletta Bio at Buy With $10 Price Target, from 8:53AM ET on Thursday Oct 10, 2024 by MT Newswires